University of North Carolina-Chapel Hill
Chapel Hill, North Carolina, 27599, United States
NCT Number: NCT00685386
The purpose of this study it to conduct a randomized, controlled, double-blinded trial of carbon dioxide (CO2) versus air insufflation during endoscopic retrograde cholangiopancreatography (ERCP).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chapel Hill, North Carolina, 27599, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The bowel lumen will be insufflated with CO2 during the endoscopy (as compared to room air).
Other names: Olympus XUCR manufacured by Olympus Medical.
During the ERCP, room air will be insufflated (current standard clinical practice) as a placebo comparator.
Time frame: pre-procedure and up to 24 hours post-procedure.
Time frame: Intra-procedure
University of North Carolina, Chapel Hill
Other
A Randomized, Controlled, Double-blind Trial of CO2 Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06005701
Behavior, Bile Duct Diseases
Buraidah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT01194063
Bile Duct Diseases, Biliary Tract Diseases
Honolulu, Hawaii, United States
View Trial DetailsNCT04510090
Bile Duct Diseases, Biliary Tract Diseases
Adelaide, South Australia, Australia
View Trial DetailsNCT02922751
Abnormalities, Multiple, Alagille Syndrome
Los Angeles, California, United States
View Trial Details